FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Ng

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Paul K Paik; Gregory J Riely; Camelia S Sima; Christopher G Azzoli; Robert T Heelan; Leonard P James; Mark G Kris; Vincent A Miller; Erin Moore; Kenneth K Ng; Naiyer A Rizvi
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Naiyer A Rizvi; Gregory J Riely; Christopher G Azzoli; Vincent A Miller; Kenneth K Ng; John Fiore; Gloria Chia; Martin Brower; Robert T Heelan; Michael J Hawkins; Mark G Kris
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
Scott A Laurie; Vincent A Miller; Stefan C Grant; Mark G Kris; Kenneth K Ng
Phase I study of green tea extract in patients with advanced lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Ng (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Paul K Paik; Gregory J Riely; Camelia S Sima; Christopher G Azzoli; Robert T Heelan; Leonard P James; Mark G Kris; Vincent A Miller; Erin Moore; Kenneth K Ng; Naiyer A Rizvi
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Cancer chemotherapy and pharmacology 2011;68(5):1331-7.
2008: Naiyer A Rizvi; Gregory J Riely; Christopher G Azzoli; Vincent A Miller; Kenneth K Ng; John Fiore; Gloria Chia; Martin Brower; Robert T Heelan; Michael J Hawkins; Mark G Kris
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):639-43.
2005: Scott A Laurie; Vincent A Miller; Stefan C Grant; Mark G Kris; Kenneth K Ng
Phase I study of green tea extract in patients with advanced lung cancer.
Cancer chemotherapy and pharmacology 2005;55(1):33-8.
2004: Lee M Krug; Govind Ragupathi; Kenneth K Ng; Chandra Hood; Harold J Jennings; Zhongwu Guo; Mark G Kris; Vincent A Miller; Barbara Pizzo; Leslie Tyson; Valerie Baez; Philip O Livingston
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):916-23.
2003: Christopher G Azzoli; Vincent A Miller; Kenneth K Ng; Lee M Krug; Martee Hensley; Eileen O'Reilly; Raymond J Muller; Mark G Kris
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.
American journal of clinical oncology 2003;26(3):247-51.
2003: Lee M Krug; Christopher G Azzoli; Mark G Kris; Vincent A Miller; Nushmia Z Khokhar; William Tong; Michelle S Ginsberg; Venkatraman E Seshan; Leslie Tyson; Barbara Pizzo; Valerie Baez; Kenneth K Ng; Francis M Sirotnak
10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2072-8.
2003: Christopher G Azzoli; Vincent A Miller; Kenneth K Ng; Lee M Krug; David Spriggs; William P Tong; Elyn Riedel; Mark G Kris
A phase I trial of perillyl alcohol in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2003;51(6):493-8.
2003: Lee M Krug; Vincent A Miller; Daniel A Filippa; Venkatraman E Seshan; Kenneth K Ng; Mark G Kris
Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine.
Lung cancer (Amsterdam, Netherlands) 2003;39(2):139-43.
2002: Robert J Downey; Kenneth K Ng; Mark G Kris; Manjit S Bains; Vincent A Miller; Robert T Heelan; Mark H Bilsky; Robert J Ginsberg; Valerie W Rusch
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis.
Lung cancer (Amsterdam, Netherlands) 2002;38(2):193-7.
2000: Lee M Krug; Kenneth K Ng; Mark G Kris; Vincent A Miller; William Tong; Robert T Heelan; L Leon; D Leung; J Kelly; Stefan C Grant; Francis M Sirotnak
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3493-8.
2000: Vincent A Miller; Lee M Krug; Kenneth K Ng; Barbara Pizzo; Wendy Perez; Robert T Heelan; Mark G Kris
Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1346-50.
2000: Vincent A Miller; Kenneth K Ng; Lee M Krug; Wendy Perez; Barbara Pizzo; Robert T Heelan; Mark G Kris
Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.
Cancer 2000;88(5):1045-50.
2000: Lee M Krug; Vincent A Miller; Gregory P Kalemkerian; M J Kraut; Kenneth K Ng; Robert T Heelan; Barbara A Pizzo; Wendy Perez; N McClean; Mark G Kris
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):227-8.
1999: Lee M Krug; Stefan C Grant; Vincent A Miller; Kenneth K Ng; Mark G Kris
Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Seminars in oncology 1999;26(5 Suppl 15):55-61.
1999: Kenneth K Ng; Mark G Kris; Robert J Ginsberg; Robert T Heelan; Katherine M W Pisters; Vincent A Miller; Stefan C Grant; Manjit S Bains; Valerie W Rusch; Kenneth E Rosenzweig; N Martini
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Cancer 1999;86(7):1189-97.
1997: Vincent A Miller; Kenneth K Ng; Stefan C Grant; Hedy L Kindler; Barbara Pizzo; Robert T Heelan; R von Roemeling; Mark G Kris
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1269-71.
1997: Mark G Kris; Vincent A Miller; Kenneth K Ng; Stefan C Grant
The development of docetaxel (Taxotere) in non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-1-S14-4.